Leveraging Genetically Engineered Mouse Models of Small Cell Lung Cancer for Advanced Therapeutic St
3 Vues
• 07/08/23
0
0
Intégrer
administrator
Les abonnés
Anna Farago, MD
We have developed a series of genetically engineered mouse models of SCLC, in which conditional deletion of the tumor suppressor genes p53 and Rb1 in pulmonary epithelial cells triggers initiation of tumors that mirror the histology
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires